Blog Posts Discuss Use Of Bedaquiline To Treat Drug-Resistant TB In India, South Africa

The BMJ Opinion: Kanchan Mukherjee: Bedaquiline for multidrug resistant TB in India — at what cost?
Kanchan Mukherjee, a medical doctor and professor at the Tata Institute of Social Sciences in Mumbai, discusses the potential benefits and challenges of a wider government rollout of bedaquiline to treat multidrug-resistant TB in India (6/20).

IDSA’s “Science Speaks”: Advocates hail South Africa bedaquiline recommendation, replacing toxic injection for patients with drug-resistant tuberculosis
Antigone Barton, senior editor and writer of “Science Speaks,” highlights South Africa’s decision to begin using bedaquiline to treat patients with drug-resistant TB and advocates’ reactions to the policy change (6/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.